Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,295 | 168 | 97.0% |
| Education | $100.94 | 2 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $518.04 | 29 | $0 (2024) |
| Daiichi Sankyo Inc. | $444.97 | 17 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $340.37 | 21 | $0 (2024) |
| Merck Sharp & Dohme LLC | $200.70 | 10 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $173.31 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $154.22 | 5 | $0 (2024) |
| ABBVIE INC. | $132.74 | 7 | $0 (2024) |
| SOBI, INC | $105.17 | 5 | $0 (2024) |
| Lilly USA, LLC | $91.51 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $80.35 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,671 | 131 | Daiichi Sankyo Inc. ($418.52) |
| 2023 | $712.41 | 38 | PFIZER INC. ($165.53) |
| 2021 | $12.38 | 1 | Pharmacyclics LLC, An AbbVie Company ($12.38) |
All Payment Transactions
170 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $28.11 | General |
| Category: Hematology | ||||||
| 12/17/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $27.87 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: ONCOLOGY | ||||||
| 12/10/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Iron Deficiency Anemia | ||||||
| 12/06/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Oncology | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Oncology | ||||||
| 12/02/2024 | SOBI, INC | VONJO (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 12/02/2024 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: ONCOLOGY | ||||||
| 11/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | DARZALEX (Biological) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Oncology | ||||||
| 11/20/2024 | PharmaEssentia USA Corporation | BESREMI (Drug) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $68.35 | General |
| Category: Oncology | ||||||
| 11/19/2024 | Coherus Biosciences Inc. | Udenyca (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Granulocyte colony stimulating factor | ||||||
| 11/18/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.71 | General |
| 11/15/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.39 | General |
| Category: ONCOLOGY | ||||||
| 11/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Oncology | ||||||
| 11/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Lilly USA, LLC | VERZENIO (Drug), JAYPIRCA | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $75.21 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2024 | Agios Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.08 | General |
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Oncology | ||||||
| 10/31/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 314 | 431 | $62,745 | $22,370 |
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 108 | $18,958 | $8,632 | 45.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 103 | 121 | $14,597 | $6,630 | 45.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 28 | 47 | $17,390 | $3,509 | 20.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 39 | $4,875 | $1,977 | 40.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $1,425 | $632.16 | 44.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 29 | 42 | $2,100 | $368.34 | 17.5% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 19 | 40 | $2,200 | $359.16 | 16.3% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 12 | 15 | $1,200 | $262.50 | 21.9% |
About Lasondra Bean, APRN
Lasondra Bean, APRN is a Family healthcare provider based in Bowling Green, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/11/2009. The National Provider Identifier (NPI) number assigned to this provider is 1710126941.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lasondra Bean, APRN has received a total of $3,396 in payments from pharmaceutical and medical device companies, with $2,671 received in 2024. These payments were reported across 170 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($3,295).
As a Medicare-enrolled provider, Bean has provided services to 314 Medicare beneficiaries, totaling 431 services with total Medicare billing of $22,370. Data is available for 1 year (2023–2023), covering 8 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Family
- Location Bowling Green, KY
- Active Since 02/11/2009
- Last Updated 01/19/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1710126941
Products in Payments
- Enhertu (Drug) $331.71
- KEYTRUDA (Biological) $167.22
- INLYTA (Drug) $137.50
- KISQALI (Drug) $112.19
- XTANDI (Drug) $103.75
- ERLEADA (Drug) $81.42
- MEKINIST (Drug) $78.14
- VONJO (Drug) $72.52
- ENHERTU (Biological) $68.26
- AYVAKIT (Drug) $66.20
- VENCLEXTA (Drug) $65.98
- INJECTAFER (Drug) $62.62
- REBLOZYL (Biological) $61.59
- ENJAYMO (Biological) $60.56
- PADCEV (Biological) $57.34
- LYNPARZA (Drug) $56.12
- BESREMI (Drug) $56.05
- IBRANCE (Drug) $52.33
- EPKINLY (Drug) $51.11
- VERZENIO (Drug) $48.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Bowling Green
Carrie Parrish Nyekan, Aprn, APRN
Family — Payments: $51,758
Ms. Joy Cornelius, Aprn, Pmhnp, APRN, PMHNP
Family — Payments: $19,769
Jeannette Dabit, Aprn, APRN
Family — Payments: $17,565
Colleen Barry, Fnp-C, FNP-C
Family — Payments: $16,695
Mrs. Ashley Towe, Aprn, APRN
Family — Payments: $11,892
Jacqueline Erbse, Aprn, Fnp-C, APRN, FNP-C
Family — Payments: $11,734